Bernard J. Zovighian - May 3, 2024 Form 4/A Insider Report for Edwards Lifesciences Corp (EW)

Role
CEO, Director
Signature
/s/ Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
May 3, 2024
Transactions value $
$0
Form type
4/A
Date filed
6/13/2024, 09:18 PM
Date Of Original Report
May 7, 2024
Previous filing
Aug 1, 2023
Next filing
May 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EW Common Stock 3.27K May 3, 2024 401(k) F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total reflects an acquisition of 580.2601 shares of the Issuer's Common Stock on May 6, 2024 under the Issuer's 401(k) Plan in a transaction exempted by Rule 16b-3, as well as 2,558 shares held under the Issuer's 401(k) Plan that were previously reported as directly held.

Remarks:

This amendment to the Form 4 filed on May 7, 2024 by the Reporting Person is filed to remove the reporting of the acquisition of shares described in Footnote 1, as it was an exempt transaction in the Issuer's Common Stock pursuant to Section 16b-3(c) of the Securities Exchange Act of 1934, as amended, and to disclose the number of shares beneficially owned indirectly by the Reporting Person as represented on the most recent statement of the Issuer's 401(k) Plan Administrator.